Zhang H, Somasundaram K, Peng Y, Tian H, Zhang H, Bi D, Weber B L, El-Deiry W S
Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104, USA.
Oncogene. 1998 Apr 2;16(13):1713-21. doi: 10.1038/sj.onc.1201932.
Mutations of the BRCA1 tumor suppressor gene are the most commonly detected alterations in familial breast and ovarian cancer. Although BRCA1 is required for normal mouse development, the molecular basis for its tumor suppressive function remains poorly understood. We show here that BRCA1 increases p53-dependent transcription from the p21WAF1/CIP1 and bax promoters. We also show that BRCA1 and p53 proteins interact both in vitro and in vivo. The interacting regions map, in vitro, to aa 224-500 of BRCA1 and the C-terminal domain of p53. Tumor-derived transactivation-deficient BRCA1 mutants are defective in co-activation of p53-dependent transcription and a truncation mutant of BRCA1 that retains the p53-interacting region acts as a dominant inhibitor of p53-dependent transcription. BRCA1 and p53 cooperatively induce apoptosis of cancer cells. The results indicate that BRCA1 and p53 may coordinately regulate gene expression in their role as tumor suppressors.
乳腺癌1号肿瘤抑制基因(BRCA1)的突变是家族性乳腺癌和卵巢癌中最常检测到的改变。尽管BRCA1是正常小鼠发育所必需的,但其肿瘤抑制功能的分子基础仍知之甚少。我们在此表明,BRCA1可增强p21WAF1/CIP1和bax启动子的p53依赖性转录。我们还表明,BRCA1和p53蛋白在体外和体内均相互作用。体外实验表明,相互作用区域位于BRCA1的第224至500位氨基酸以及p53的C末端结构域。肿瘤来源的转录激活缺陷型BRCA1突变体在p53依赖性转录的共激活方面存在缺陷,而保留p53相互作用区域的BRCA1截短突变体可作为p53依赖性转录的显性抑制剂。BRCA1和p53协同诱导癌细胞凋亡。结果表明,BRCA1和p53可能在其作为肿瘤抑制因子的作用中协调调节基因表达。